Astria Therapeutics Ownership | Who Owns Astria Therapeutics?

Astria Therapeutics Ownership Summary

Astria Therapeutics is owned by 103.85% institutional investors, 0.49% insiders. Fmr is the largest institutional shareholder, holding 13.85% of ATXS shares. FIAM Small Cap Core CIT Cl B is the top mutual fund, with 3.19% of its assets in Astria Therapeutics shares.

ATXS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Astria Therapeutics	103.85%	0.49%	-4.33%
Sector	Healthcare Stocks	279.42%	10.64%	-190.05%
Industry	Biotech Stocks	64.05%	10.69%	25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	7.82M	13.85%	$69.94M
Perceptive advisors	6.49M	11.18%	$34.76M
Vestal point capital, lp	4.52M	7.80%	$24.24M
Fcpm iii services b.v.	4.11M	7.08%	$23.41M
Blackrock	3.52M	6.73%	$32.01M
Blackrock funding, inc. /de	3.70M	6.38%	$19.83M
Fairmount funds management	3.55M	6.13%	$19.05M
Tcg crossover management	2.76M	4.76%	$14.80M
Vanguard group	2.68M	4.74%	$23.94M
Vr adviser	2.46M	4.24%	$13.17M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Fcpm iii services b.v.	4.11M	6.34%	$23.41M
Fairmount funds management	3.55M	2.47%	$19.05M
Tcg crossover management	2.76M	1.69%	$14.80M
Perceptive advisors	6.49M	1.29%	$34.76M
Vestal point capital, lp	4.52M	1.28%	$24.24M
Vr adviser	2.46M	0.99%	$13.17M
Vivo capital	1.55M	0.85%	$8.32M
Sio capital management	318.26K	0.65%	$1.71M
Dafna capital management	324.77K	0.48%	$1.74M
Logos global management lp	700.00K	0.42%	$3.75M

Top Buyers

Holder	Shares	% Assets	Change
Ubs group	1.37M	0.00%	1.31M
Point72 asset management	762.76K	0.01%	762.76K
Nantahala capital management	1.07M	0.22%	400.00K
Vestal point capital, lp	4.52M	1.28%	342.00K
Affinity asset advisors	300.00K	0.22%	300.00K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-5.11M
Cormorant asset management, lp	-	-	-1.30M
Avidity partners management lp	-	-	-982.00K
Caption management	-	-	-976.30K
Artal group	-	-	-884.21K

New Positions

Holder	Shares	% Assets	Change	Value
Point72 asset management	762.76K	0.01%	762.76K	$4.09M
Affinity asset advisors	300.00K	0.22%	300.00K	$1.61M
Clarivest asset management	80.31K	0.07%	80.31K	$730.87K
Cantor fitzgerald, l. p.	54.63K	0.01%	54.63K	$292.84K
Xtx topco	36.25K	0.01%	36.25K	$194.29K

Sold Out

Holder	Change
Fortitude family office	-4.00
Nelson, van denburg & campbell wealth management group	-7.00
Pnc financial services group	-10.00
Srs capital advisors	-65.00
Cwm	-67.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	115	0.88%	58,322,222	-0.44%	103	0.97%	54	-19.40%	31	29.17%
Dec 31, 2024	113	5.61%	58,576,189	3.65%	103	1.04%	66	37.50%	24	-36.84%
Sep 30, 2024	107	3.88%	56,513,751	1.68%	100	0.89%	48	-22.58%	38	46.15%
Jun 30, 2024	103	-17.60%	55,578,904	-3.56%	106	0.88%	62	-21.52%	26	13.04%
Mar 31, 2024	125	52.44%	57,630,802	56.36%	110	0.74%	79	43.64%	23	43.75%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
FIAM Small Cap Core CIT Cl B	1.80M	3.19%	597.00K
Vanguard US Total Market Shares ETF	1.56M	2.77%	-
Vanguard Total Stock Mkt Idx Inv	1.53M	2.71%	-33.70K
Fidelity Small Cap Growth	1.35M	2.40%	-
FIAM Small Cap Core Composite	1.22M	2.17%	-29.00K
iShares Russell 2000 ETF	1.00M	1.78%	-19.11K
Strategic Advisers Fidelity US TtlStk	692.81K	1.23%	-
Fidelity Small Cap Growth K6	599.44K	1.06%	-
Fidelity Series Small Cap Core	581.39K	1.03%	242.60K
Heptagon Driehaus US Micro Cap Eq C$ Acc	554.83K	0.98%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 01, 2024	Morabito Christopher	Chief Medical Officer	Sell	$135.94K
Feb 01, 2024	PERCEPTIVE ADVISORS LLC	-	Buy	$30.00M
Jan 29, 2024	Morabito Christopher	Chief Medical Officer	Sell	$102.55K
Jan 26, 2024	Morabito Christopher	Chief Medical Officer	Sell	$8.81K
Dec 21, 2023	PERCEPTIVE ADVISORS LLC	-	Buy	$4.59M

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q2	-	1
2024 Q1	1	2
2023 Q4	7	-

ATXS Ownership FAQ

Who Owns Astria Therapeutics?

Astria Therapeutics shareholders are primarily institutional investors at 103.85%, followed by 0.49% insiders and -4.34% retail investors. The average institutional ownership in Astria Therapeutics's industry, Biotech Stocks , is 64.05%, which Astria Therapeutics exceeds.

Who owns the most shares of Astria Therapeutics?

Astria Therapeutics’s largest shareholders are Fmr (7.82M shares, 13.85%), Perceptive advisors (6.49M shares, 11.18%), and Vestal point capital, lp (4.52M shares, 7.80%). Together, they hold 32.83% of Astria Therapeutics’s total shares outstanding.

Does Blackrock own Astria Therapeutics?

Yes, BlackRock owns 6.73% of Astria Therapeutics, totaling 3.52M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 32.01M$. In the last quarter, BlackRock decreased its holdings by -67.913K shares, a -1.89% change.

Who is Astria Therapeutics’s biggest shareholder by percentage of total assets invested?

Fcpm iii services b.v is Astria Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.34% of its assets in 4.11M Astria Therapeutics shares, valued at 23.41M$.

Who is the top mutual fund holder of Astria Therapeutics shares?

FIAM Small Cap Core CIT Cl B is the top mutual fund holder of Astria Therapeutics shares, with 3.19% of its total shares outstanding invested in 1.8M Astria Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools